-The Hindu It is not the responsibility of the government alone to act in order to curb corruption; corporate firms need to be proactive as well in checking fraudulent financial practices The winter session of Parliament witnessed a noisy debate on the black money controversy. Governments of all hues have disappointed the Indian janata on the issue of black money and the failure is often associated with a perceived nexus between politicians...

-The Hindu Providing people with a modest basic income instead of subsidies would save public revenue With oil prices falling, it was perhaps a good time to fade out fuel subsidies. All subsidies are inefficient and distortionary, and most are regressive. The same could be said of costly public works schemes as well. By contrast, the debate on direct benefit transfers has moved into a more sensible phase, with the posturing criticism of...

-Economic and Political Weekly   The runaway growth in states of subsidised solar pumps, which provide quality energy at near-zero marginal cost, can pose a bigger threat of groundwater over-exploitation than free power has done so far. The best way to meet this threat is by paying farmers to "grow" solar power as a remunerative cash crop. Doing so can reduce pressure on aquifers, cut the subsidy burden on electricity companies, reduce...

-The Indian Express The aftermath of the terrible deaths of women who underwent sterilisation surgeries in Bilaspur in Chhattisgarh has been full of stories about what actually happened. Spurious drugs and an overenthusiastic doctor who cut corners on ensuring quality vie for immediate blame. Beyond these, many have spoken about pervasive biases of gender and caste that wreak havoc on the lives of poor women, and also of family planning policies...

-Business Standard Indian and other generic drug firms face prospect of US legislature debating compensation for undue price rises Indian generic drug makers might, if a proposed US law comes about, need to pay a rebate to the federal Medicaid programme there when prices of their medications outpace inflation. A Bill is to be introduced in the US Senate by a member, aimed to cushion the impact on taxpayers in this manner...